Adlai Nortye Ltd.
NASDAQ:ANLBiotechnology
-$0.11 today
- Market cap
- $463.92M
- Beta
- 0.99
- P/E (TTM)
- -3.0
- EPS (TTM)
- -$3.33
Volume 0.45M
Average 0.35M
ANL Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Adlai Nortye Ltd.NASDAQ: ANL
Capital Expenditures · Q2 FY2024 · quarter ended Jun 2024
Capital expenditures declines year over year
Q2 FY2024 capital expenditures of $61K (cash outflow) fell 3.2% year over year, ahead of the -64.3% change in trailing-twelve-month capital expenditures. Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at -47.1% a year.
Context
- Capital expenditures amounted to 3.7% of revenue in FY2025.
- Capital expenditures grew in size in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of -3.2% holds above the trailing-twelve-month pace of -64.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (187.49K) USD
- Year-over-year change
- -10.3%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (187.49K) | -10.3% |
| FY2024 | 2024-12-31 | (170K) | +15.0% |
| FY2023 | 2023-12-31 | (200K) | +84.2% |
| FY2022 | 2022-12-31 | (1.27M) | -13.2% |
| FY2021 | 2021-12-31 | (1.12M) | — |
Capital Expenditures vs competitors
How ANL compares with its peers on the latest reported figures
- ANL's LTM Jun 2024 capital expenditures of $237K is the 2nd largest of the 7 companies compared; the peer median is $61.5K.
- Capital expenditures amounts to 3.7% of revenue for ANL, versus a peer median of 0.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $1.35M | +19114.3% | — | 2.7% | |
| LTM Jun 2024 | $237K | — | -47.1% | 3.7% | |
| LTM Mar 2026 | $229K | +536.1% | -13.5% | — | |
| LTM Jun 2026 | $101K | -74.0% | -1.5% | 0.1% | |
| LTM Mar 2026 | $22K | -97.4% | -65.4% | 0.1% | |
| LTM Dec 2025 | $0 | — | -14.3% | 0.0% | |
| FY2025 | $0 | +100.0% | — | 0.0% | |
| Peer median (excluding ANL) | $61.5K | +100.0% | -13.9% | 0.1% | |
Competitors are the stored peer set for ANL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (56.68M) | (58.79M) | (104.87M) | (51.87M) | (35.62M) |
| Depreciation & Amortization | 1.83M | 2.04M | 2.22M | 1.87M | 1.42M |
| Deferred Income Tax | (67K) | (1.04M) | 0 | 0 | 0 |
| Stock-Based Compensation | 3.39M | 6.08M | 4.33M | 2.45M | 0 |
| Change in Working Capital | 250K | 15.25M | 6.12M | (5.54M) | (2.29M) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 600K | 10.12M | 1.25M | (4.2M) | 2.5M |
| Other Working Capital | (350K) | 5.13M | 4.87M | (1.34M) | (4.79M) |
| Other Non-Cash Items | 48.25M | (6.76M) | 35.54M | 1.27M | 2.96M |
| Operating Cash Flow | (3.03M) | (43.22M) | (56.65M) | (51.82M) | (33.54M) |
| Capital Expenditures | (1.12M) | (1.27M) | (200K) | (170K) | (187.49K) |
| Acquisitions (Net) | (102K) | (2K) | 0 | (4.21M) | 0 |
| Purchases of Investments | (81.23M) | (58.98M) | (31.83M) | (60.55M) | (20.49M) |
| Sales of Investments | 27.47M | 88.06M | 21.02M | 92.26M | 5.05M |
| Other Investing Activities | 134K | 569K | 53.6K | 734K | 0 |
| Investing Cash Flow | (54.86M) | 28.38M | (10.95M) | 28.07M | (15.62M) |
| Debt Repayment | 1.02M | (6.49M) | 25.06M | (4.86M) | (2.02M) |
| Common Stock Issued | 97.37M | 0 | 91.78M | 152.08K | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (1.19M) | (292K) | (602K) | (1.87M) | (1.81M) |
| Financing Cash Flow | 97.2M | (6.78M) | 116.24M | (6.58M) | (3.82M) |
| Effect of Forex Changes | 561K | 254K | 100K | (257K) | 15.87M |
| Net Change in Cash | 39.87M | (21.37M) | 48.73M | (30.59M) | (37.12M) |
| Free Cash Flow | (4.15M) | (44.49M) | (56.85M) | (51.99M) | (33.73M) |
Adlai Nortye Ltd.
NASDAQ:ANL
Intrinsic Alpha fair value
Locked
Current Price
$8.74
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.